- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05015101
Evaluation of the Clinical and Radiological Outcome of Uncemented Femoral Stems According to Their Proximal Coating (ETNA)
Evaluation of the Clinical and Radiological Outcome of Uncemented Femoral Stems According to Their Proximal Coating.
Evaluation of the clinical and radiological outcome of uncemented femoral stems according to their proximal coating.
Retrospective study
Study Overview
Detailed Description
On a large population of patients having undergone total hip arthroplasty, divided into two cohorts constituted according to the type of femoral stem implanted (with or without proximal coating by MectaGrip):
Primary objective: To compare between the two groups the radiological osseointegration of the stems five years after arthroplasty.
Secondary objectives: To compare between the groups
- The functional outcome of the arthroplasty
- The frequency of radiological abnormalities (stress shielding, osteolysis, periprosthetic fractures or cracks, periprosthetic ossifications)
- Frequency of complications
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75005
- Clinique du Sport
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient aged 18 years or older, having been informed of the research
- A patient with at least five years of uncemented total hip replacement implanted as a first-line procedure
- A patient who has been regularly monitored since surgery and for whom all clinical and radiological data are available at the five-year follow-up visit
Exclusion Criteria:
- Patient operated for revision
- History of femoral fracture (pre or per operative)
- Chronic treatment likely to affect calcium metabolism and ossification
- Patient under legal protection, guardianship or curatorship
- A patient who has indicated his or her opposition to the use of his or her medical data (by completing and returning the non-opposition form that will be sent to him or her).
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engh and Massin Score
Time Frame: 5 years
|
The osseointegration of each stem will be assessed by the Engh and Massin score which evaluates the fixation (bone margins and bridges) and the stability of the stem (margins, pedestal, remodelling of the calcar, deterioration of the prosthesis-bone interface, migration, and particles) by associating negative or positive values for each of the parameters.
The total constitutes an anatomopathological diagnosis of "confirmed bone rehab" (+ 10 pts and more), suspected (between 0 and + 10 pts), "fibrous encapsulation" (between - 10 and 0 pts) or an "unstable" prosthesis (below - 10 pts).
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stability of the femoral stem: axial migration (sinking)
Time Frame: 5 years
|
Radiological assessment of the stability of the femoral stem: axial migration (sinking)
|
5 years
|
|
Stability of the femoral stem: frontal migration (varisation)
Time Frame: 5 years
|
Radiological assessment of the stability of the femoral stem: frontal migration (varisation)
|
5 years
|
|
Gruen's zones assessment
Time Frame: 5 years
|
Images of edging, osteolysis, stress shielding according to Gruen's zones
|
5 years
|
|
Periprosthetic ossifications (Brooker classification)
Time Frame: 5 years
|
Periprosthetic ossifications (Brooker classification)
|
5 years
|
|
Periprosthetic fractures (Vancouver classification)
Time Frame: 5 years
|
Periprosthetic fractures (Vancouver classification)
|
5 years
|
|
Harris Hip Score (HHS)
Time Frame: 5 years
|
The Harris Hip Score (HHS) consists of a history part and a clinical examination part that takes into account pain, function and mobility of the hip.
A score between 90 and 100 points is defined as excellent, between 80 and 90 as good, between 70 and 80 as fair and below 70 as poor.
|
5 years
|
|
Oxford hip score
Time Frame: 5 years
|
The Oxford score is a self-assessment of hip joint function consisting of 12 questions scored from 0 to 4. The total score is calculated by adding up the results of each question.
The lower the score, the more severe the functional impact.
|
5 years
|
|
Forgotten Joint Score
Time Frame: 5 years
|
Le Forgotten Joint Score (FJS-12), est un auto-questionnaire compose de 12 questions évaluant le degré d'oubli des prothèses de hanche dans une situation donnée de la vie quotidienne.
Chaque réponse est choisie dans une échelle de Likert à 5 points avec les options de réponse allant de jamais (0) la plupart du temps (4).
|
5 years
|
|
Life span of prostheses
Time Frame: 5 years
|
The life span is the time between the implantation of the prosthesis and its complete or partial surgical revision.
|
5 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Frédéric LAUDE, MD PD, Clinique du Sport
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- COS-RGDS-2019-12-012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthroplasty
-
Copenhagen University Hospital, HvidovreUniversity of Southern Denmark; University Hospital Bispebjerg and FrederiksbergNot yet recruitingKnee Arthroplasty | Total Knee Arthroplasty | Unicompartmental Knee Arthroplasty
-
Fondazione Don Carlo Gnocchi OnlusCompletedKnee Arthroplasty | Hip Arthroplasty
-
Hospital for Special Surgery, New YorkMedical College of WisconsinRecruitingComplications; Arthroplasty | Complications; Arthroplasty, MechanicalUnited States
-
Haute Ecole de Santé VaudNot yet recruitingArthroplasty, Replacement, Hip | Arthroplasty Replacement, KneeSwitzerland
-
University of British ColumbiaThe Arthritis Society, Canada; Centre for Aging SMART; Centre for Advancing Health...Not yet recruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipCanada
-
University Hospital, Strasbourg, FranceRecruitingArthroplasty, Hip Replacement | Arthroplasty, Knee ReplacementFrance
-
Henry Ford Health SystemConsumer Sleep SolutionsNot yet recruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipUnited States
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
The Cleveland ClinicZimmer Biomet; Accelero Health Partners, LLCCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipUnited States
-
The Cleveland ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipUnited States
Clinical Trials on Cohort observation
-
Royal Marsden NHS Foundation TrustUniversity of WarwickUnknownCancer | Toxicity | MalignancyUnited Kingdom
-
The First Hospital of Jilin UniversityCompleted
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Y Biologics Inc.Novotech (Australia) Pty LimitedActive, not recruitingAdvanced Solid TumorsKorea, Republic of, Thailand, Australia
-
Institut du Cancer de Montpellier - Val d'AurelleRecruiting
-
Uniquity One (UNI)CompletedHealthyUnited States
-
XOMA (US) LLCCompletedCongenital HyperinsulinismUnited Kingdom, United States
-
MedImmune LLCCompletedHealthyUnited States, Australia, Spain, Germany, Canada, Finland, South Africa, Brazil, Israel